중동 및 아프리카 제약용 분리기 시장 – 2029년까지의 산업 동향 및 예측

중동 및 아프리카 제약용 분리기 시장 분석 및 통찰력

제약용 분리기는 제약 산업에서 오염 없는 장벽 시스템으로 사용됩니다. 미생물 검사, 세포 치료 처리, 첨단 제약(ATMP) 제조, 멸균 주사 제품의 계량, 포장 및 유통은 제약용 분리기의 몇 가지 응용 분야일 뿐입니다. 제약용 분리기의 사용은 개발도상국과 선진국에서 제약 시장의 지속적인 성장과 혁신적인 치료법을 생산하기 위한 R&D 지출 증가로 인해 촉진되었습니다. 첨단 의료용 절연체와 제약 산업의 요구 사항으로 인해 주요 제조업체는 의료용 절연체 산업을 성장시켰습니다. 유해 화합물의 사용 증가, 비준수 비용 증가, 연구실 증가는 예측 기간 동안 제약용 분리기 시장을 주도하는 중요한 요인입니다.

그러나 대부분의 전문가들은 규제 기관이 더 이상 제약용 절연체 개발과 같은 획기적인 발전을 방해할 수 없다는 데 동의하지 않습니다.

Data Bridge Market Research는 중동 및 아프리카 제약 아이솔레이터 시장이 2029년까지 2억 3,279만 달러에 도달할 것으로 예상되며, 예측 기간 동안 CAGR은 12.0%라고 분석했습니다. 유형은 제약 아이솔레이터 중동 및 아프리카의 빠른 수요로 인해 시장에서 가장 큰 유형 세그먼트를 차지합니다. 이 시장 보고서는 또한 가격 분석, 특허 분석 및 심층적인 기술 발전을 다룹니다.

Middle East & Africa Pharmaceutical Isolator Market Definition

The isolation concept protects the process from the Operator and or the operator from the process, while protecting the environment. The key to containment, is minimal exposure. By controlling the exposure range below the hazard level set for the compound, the Operator and the environment are properly protected. Hence, the product is protected and therefore a key regulatory issue is addressed. A pharmaceutical isolator is a sealed bacterial enclosure used in the pharmaceutical surrounding for aseptic filling and toxic process. It is made of a perfectly sterile main isolator where the products are handled, stored or packaged using shoulder-high gloves placed on one of the walls. The pharmaceutical isolator enables the control and containment of pharmaceutical processes. The conditions required for working of a pharmaceutical isolator are sterile environment and free of viable microorganisms. A pharmaceutical isolator ensures that production area and aseptic environment are placed in separate positions. A pharmaceutical industry isolator is cost effective and efficient, in comparison to cleanrooms for the pharmaceutical industry in an aseptic environment. It creates a controlled atmosphere during the microbial and drug production process by adjusting with the different standards certification standard required for isolators and restricted access barriers. It ensures the protection of the product, the operators and the environment at the same time.

The abundant applications of pharmaceutical isolators, vary for production and control purposes. It is used while handling, transferring or packing solid semi-solid or powder pharma drugs, handling and filing solutions and infusions. The pharmaceutical isolators are applied in sterility testing, aseptic handling of tissues or biological production systems or pathogenic samples, etc. It can be used for the production and control of drugs and pharmaceutical products. The surge in demand for the isolators across pharmaceutical and biotechnology industry, along with low operational cost, high maintenance of aseptic condition in the production of pharmaceutical products and growing demand of biopharmaceutical industry are the factors expected to drive the market growth, in the forecast period.

Also, strategic initiative by market players, technological progressions in pharmaceutical isolators, high sterility assurance and increasing investment for healthcare infrastructure. These factors increase in the demand for pharmaceutical isolators market.

Middle East & Africa Pharmaceutical Isolator Market Dynamics

This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:    

Drivers

Growing demand for the pharmaceutical isolators across booming pharmaceutical

Pharmaceutical isolator is a separative device that divides a pharmaceutical procedure or activity from the operator and the adjacent environment. It is used for various purposes such as:

• Providing a categorized aseptic environment for an activity or procedure and guarding it from microbial and non-microbial contamination rising from the operator and adjacent environment which is referred to product protection.
• Protective product from contamination produced by other product and procedure, moreover at the same time or during earlier operations. This is referred to as safeguard against method generated contamination or cross- contamination.

The Increasing contamination problems in the manufacturing unit in which comes isolator that create a demand for Pharmaceutical isolator that helps in contamination and de-contamination.

• Low operational cost of pharmaceutical isolators

Enclosures that are sealed to some standard of leak tightness that comprises inside qualified controlled environment, at modification with the surrounding conditions isolator application reaches from R&D by the production of pharmaceuticals to laboratory use, especially for the microbiological quality control. Whereas pharmaceutical aseptic production has extremely high standards of cleanness almost completely particle free and germ free environments for the aseptic production.

Due to growth in the pharma industry and the widening product range more and more manufacturers and suppliers needs to think about investments in latest added technologies of the clean room technology.

Aseptic processing of the pharmaceutical drugs is the major factor need to be included in good manufacturing practices meeting the government regulations. The high cost of the maintenance of the aseptic condition by clean room technology which is around 62% higher than the pharmaceutical isolators, shifting the manufacturers to acquire isolator’s technology and constraining the overall manufacturing cost of the pharmaceutical products.

Restraint

• Stringent Governmental Regulations               

Active Pharmaceutical Ingredients (API) and intermediates for pharmaceutical use (for instance biological, radiopharmaceutical, and pharmaceutical) and those used to production drugs for clinical trials are regulated under the Divisions 1A and 2, Part C of the Food and Drug Regulations.

• Division 1A, Part C of the Food and Drug Regulations describes activities for which Good Manufacturing Practices (GMP) compliance is required and must be demonstrated prior to the issuance of an API establishment license (EL).
• Division 2, Part C of the Food and Drug Regulations defines the requirements for the GMP of APIs and API intermediates, which are interpreted in the present guidance document.

Due to this strict regulation by the government that has to be followed for the production by the Good Manufacturing Practices (GMP) Guidelines for Active Pharmaceutical Ingredients (API) - (GUI-0104) which constraining the market growth rate.

Opportunity

• Strategic initiatives by market players

The rise in the pharmaceutical isolators market increases the need for strategic business ideas. It includes a partnership, business expansion, and other development. The rising demand for pharmaceuticals is significantly increasing the demand for excipient and to cope with this demand companies are building new manufacturing sites among other strategic initiatives.

These strategic initiatives such as product launches, agreement and business expansion by the major market player will boost the pharmaceutical isolator market growth and is expected to act as an opportunity for the Middle East & Africa medical display market.

Challenge

Lack of skilled expertise

The shortage of skilled expertise would challenge the pace of recovery and growth in one place. Often, the people who are unemployed in one place have skills that are in short supply elsewhere. Moreover, rapid technological advancement in this field also leads to lack of expertise.

Lack of skilled professionals while handling the pharmaceutical isolators poses a major challenge while selecting and developing the pharmaceutical isolators. The data by the Phys.org 2003 mentions the medical display industries are facing a shortage of workers due to increase demand of pharmaceutical isolators in Asia-Pacific region and severe scarcity of micro chips used in LED and LCD display, which increases the price lead times of LCD production.

As skill demands are too high, it has manifested as a challenge to retain and manage skill-specified professionals. Moreover, technological advancement is another aspect that leads to the increased demand for skilled professionals. Neurologists report significant unmet supportive care needs and barriers in their centers with only a small minority rating themselves as competently providing supportive care. There is an urgent need for education of neurologists and professionals for treatment of dementia and procuring available supportive care resources. Lack of trained and experienced professionals and persistent skill gaps limit the employability prospects and access to quality jobs. It is therefore apparent that availability of professionals equipped with adequate skills is expected to challenge the market growth.

Post-COVID-19 Impact on Middle East & Africa Pharmaceutical Isolator Market

The COVID-19 pandemic has become the world's most serious threat. It wreaked havoc in many stores and businesses around the world. The pandemic, on the other hand, has provided many opportunities for pharmaceutical and biopharmaceutical companies to expand their research and development activities to develop new vaccines against the new coronavirus. Companies are conducting clinical trials to try to stop the spread of the COVID-19 virus. Pharmaceutical insulator suppliers to biopharmaceutical organizations have more opportunities as the number of clinical trials increases.

Manufacturers are making various strategic decisions to bounce back post-COVID-19. The players are conducting multiple R&D activities and product launch and strategic partnerships to improve the technology and test results involved in the pharmaceutical medical display market.

Recent Developments

• In June 2022, the company announced a partnership with Medical Supply Company (MSC) to market and service Jacomex equipment to the pharmaceutical and pharmaceutical industries in Ireland. MSC has many years of recognized expertise in the market with field teams closest to customers and company’s commercial team currently working abroad had the pleasure of welcoming Cian Murphy and finalizing the agreement between Jacomex and MSC. The beginning of a long and fruitful collaboration. This has helped the company to expand their business.
• In January 2022, Clario partnered with XingImaging, a radiopharmaceutical production and positron emission tomography (PET) acquisition company, to deliver PET imaging clinical trials for testing novel therapeutics in China. The partnership offers to share the joint resources and neuroscience experts of Clario and XingImaging to expedite the startup of clinical trials and drug discovery in China.

Middle East & Africa Pharmaceutical isolator market Scope

Middle East & Africa pharmaceutical isolator market is segmented into type, pressure, application, configuration, system type, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY TYPE

• ASEPTIC ISOLATORS
• CONTAINMENT ISOLATORS
• BIO ISOLATORS
• SAMPLING AND WEIGHING ISOLATORS
• ACTIVE PHARMACEUTICAL INGREDIENT (API) MANUFACTURING ISOLATORS
• RADIOPHARMACEUTICAL ISOLATORS
• PRODUCTION ISOLATORS
• OTHERS

On the basis of type, the Middle East & Africa pharmaceutical isolator market is segmented into aseptic isolators, containment isolators, bio isolators, sampling and weighing isolators, active pharmaceutical ingredient (API) manufacturing isolators, radiopharmaceutical isolators, production isolators, others.

MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY SYSTEM TYPE

• CLOSED SYSTEM
• OPEN SYSTEM

On the basis of system type, the Middle East & Africa pharmaceutical isolator market is segmented into closed system, open system.

MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY PRESSURE

• POSITIVE PRESSURE
• NEGATIVE PRESSURE

On the basis of pressure, the Middle East & Africa pharmaceutical isolator market is segmented into positive pressure and negative pressure.

MIDDLE EAST & AFRICA PHARMACEUTICAL ISOLATOR MARKET, BY CONFIGURATION

• FLOOR STANDING
• MODULAR
• MOBILE
• COMPACT
• TABLE TOP
• PORTABLE
• OTHERS

중동 및 아프리카 약제용 분리기 시장은 구성을 기준으로 바닥형, 모듈형, 이동식, 콤팩트형, 테이블탑형, 휴대형, 기타로 구분됩니다.

중동 및 아프리카 제약용 분리기 시장, 응용 분야별

• 무균 테스트
• 조작
• 샘플링/ 무게 측정/ 분포
• 의료기기 제조
• 기타

중동 및 아프리카 제약용 분리기 시장은 응용 분야를 기준으로 무균 테스트, 제조, 샘플링/계량/유통, 의료 기기 제조 및 기타로 세분화됩니다.

중동 및 아프리카 제약 분리기 시장, 최종 사용자별

• 병원
• 진단 실험실
• 학술 및 연구 기관
• 제약 및 생명공학 회사
• 계약 연구 기관
• 기타

중동 및 아프리카 제약용 분리기 시장은 최종 사용자를 기준으로 병원, 진단 실험실, 학술 및 연구 기관, 제약 및 생명 공학 회사, 계약 연구 기관 및 기타로 구분됩니다.

중동 및 아프리카 제약 분리기 시장, 유통 채널별

• 직접 입찰
• 소매 판매
• 제3자 유통업체

중동 및 아프리카 제약용 분리기 시장은 유통 채널을 기준으로 직접 입찰, 소매 판매, 제3자 유통업체로 구분됩니다.

중동 및 아프리카 제약용 분리기 시장 지역 분석/통찰력

중동 및 아프리카 제약용 분리기 시장을 분석하고, 유형, 압력, 응용 분야, 구성, 시스템 유형, 최종 사용자 및 유통 채널에 대한 시장 규모 정보를 제공합니다.

이 시장 보고서에 포함된 국가로는 남아프리카공화국, 사우디아라비아, UAE, 이집트, 이스라엘, 그리고 나머지 중동과 아프리카 국가가 있습니다.

2022년, 남아프리카는 제약용 분리기의 기술적 발전과 제약용 분리기 산업의 로봇 기술의 미래 증가로 인해 주도적인 위치에 있습니다.

보고서의 국가 섹션은 또한 개별 시장 영향 요인과 국내 시장의 현재 및 미래 트렌드에 영향을 미치는 규제 변화를 제공합니다. 신규 판매, 교체 판매, 국가 인구 통계, 규제 조치 및 수출입 관세와 같은 데이터 포인트는 개별 국가의 시장 시나리오를 예측하는 데 사용되는 주요 포인터 중 일부입니다. 또한 중동 및 아프리카 브랜드의 존재 및 가용성과 지역 및 국내 브랜드와의 대규모 또는 희소한 경쟁으로 인해 직면한 과제, 판매 채널의 영향이 국가 데이터에 대한 예측 분석을 제공하는 동안 고려됩니다.

경쟁 환경 및 중동 및 아프리카 제약용 분리기 시장 점유율 분석

중동 및 아프리카 제약 아이솔레이터 시장 경쟁 구도는 경쟁자별 세부 정보를 제공합니다. 포함된 세부 정보에는 회사 개요, 회사 재무, 창출된 수익, 시장 잠재력, R&D 투자, 새로운 시장 이니셔티브, 생산 현장 및 시설, 회사의 강점과 약점, 제품 출시, 제품 시험 파이프라인, 제품 승인, 특허, 제품 폭 및 호흡, 응용 프로그램 우세, 기술 수명선 곡선이 있습니다. 위에 제공된 데이터 포인트는 중동 및 아프리카 제약 아이솔레이터 시장에 대한 회사의 초점과만 관련이 있습니다.

중동 및 아프리카 제약용 분리기 시장에서 활동하는 주요 기업으로는 Getinge, SKAN AG, Hosokawa micron ltd, Gelman Singapore, Azbil Corporation, Germfree Laboratories, Inc., M. Braun Inertgas-Systeme Gmbh, Nuaire, Iteco SRL, Comecer SPA, Hecht Technologie Gmbh, Steriline SRL, Envair Limited, Tema Sinergie SPA, Schematic Engineering Industries, Chiyoda Corporation, Chamunda Pharma Machinery Pvt. Ltd, Bioquell (Ecolab Solution), Jacomex, Fedegari Autoclavi SpA, LAF Technologies, ISO Tech Design, Cytiva, Esco Pharma 등이 있습니다.

연구 방법론: 중동 및 아프리카 제약 아이솔레이터 시장

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석 및 추정됩니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. DBMR 연구팀에서 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석 및 기본(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 이 외에도 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 회사 시장 점유율 분석, 측정 표준, 중동 및 아프리카 대 지역, 공급업체 점유율 분석이 포함됩니다. 추가 문의 사항이 있는 경우 분석가 전화를 요청하십시오.

SKU-35231